Zifi-O 100 DT Tablet is a combination antibiotic formulation containing Cefixime 100 mg and Ofloxacin 100 mg, designed for the treatment of a broad spectrum of bacterial infections. Cefixime, a third-generation cephalosporin, exhibits bactericidal activity by inhibiting bacterial cell wall synthesis, making it effective against various Gram-positive and Gram-negative pathogens. Ofloxacin, a fluoroquinolone antibiotic, acts by inhibiting bacterial DNA gyrase and topoisomerase IV, thereby preventing bacterial replication and transcription. The dual mechanism of action provides a synergistic effect, enhancing antimicrobial efficacy and reducing the risk of resistance development. Zifi-O 100 DT is indicated for infections such as urinary tract infections, respiratory tract infections, gastrointestinal infections, skin and soft tissue infections, and sexually transmitted infections caused by susceptible organisms. The tablet is formulated as a dispersible tablet, facilitating ease of administration and improved patient compliance, especially in populations with swallowing difficulties. It is essential to use this medication under medical supervision, adhering to prescribed dosages and duration to ensure optimal therapeutic outcomes and minimize adverse effects. Common side effects may include gastrointestinal disturbances, hypersensitivity reactions, and potential effects on the central nervous system. Caution is advised in patients with a history of hypersensitivity to cephalosporins or fluoroquinolones, and renal or hepatic impairment.